Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.

Annals of hematology - 1 Feb 2020

Wang Xiao-Rui, Chang Yan, Yuan Xiao-Ying, Wang Ya-Zhe, Qin Ya-Zhen, Ruan Guo-Rui, Lai Yue-Yun, Liu Yan-Rong

Abstract excerpt

Many studies have confirmed that overexpressed WT1 exists in leukemic cells, especially in AML. However, the immunophenotypic features of this sort of leukemic cells remain to be unclarified. We retrospectively analyzed the immunophenotype of 283 newly diagnosed AML patients with intermediated and poor cytogenetic risk to evaluate the correlation between phenotype and WT1 overexpression. EVI1 transcripts,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antigens, Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Immunophenotyping

Share to Leukemia, Myeloid, Acute

Share to Nuclear Proteins

Share to Nucleophosmin

Share to WT1 Proteins

Source

Identifiers

PMID: 31900500
DOI: 10.1007/s00277-019-03808-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.PMID 31900500Read ↗

High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk.Semantic proximity Read ↗

Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia.Semantic proximity Read ↗

Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.Semantic proximity Read ↗

Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.Semantic proximity Read ↗

Frequency and Clinical Impact of WT1 Mutations in the Context of CEBPA-Mutated Acute Myeloid LeukemiaSemantic proximity Read ↗

[EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia].Semantic proximity Read ↗

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia.Semantic proximity Read ↗

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].Semantic proximity Read ↗

Wilms' tumor gene 1 in hematological malignancies: friend or foe?Semantic proximity Read ↗

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.Semantic proximity Read ↗

CD123 Is Consistently Expressed on NPM1-Mutated AML CellsSemantic proximity Read ↗

The many facets of WT1 in acute myeloid leukemia: clarity remains elusive.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.